Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.6 ILa | -3.70% | -3.70% | 0.00% |
05-12 | Transcript : Can-Fite BioPharma Ltd. - Special Call | |
05-09 | Can-Fite BioPharma Ltd. Announces FDA Grants IND Clearance for Namodenoson to Treat MASH Patients in a Phase IIb Study | CI |
- Stock Market
- Equities
- CANF Stock
- News Can-Fite BioPharma Ltd.